No recurrent severe immune-related hepatitis during PD-L1 therapy after PD-1-related hepatitis in advanced gastroesophageal junction adenocarcinoma: a case report
No recurrent severe immune-related hepatitis during PD-L1 therapy after PD-1-related hepatitis in advanced gastroesophageal junction adenocarcinoma: a case report. // Seminars in Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0093775426001168?dgcid=rss_sd_all
No recurrent severe immune-related hepatitis during PD-L1 therapy after PD-1-related hepatitis in advanced gastroesophageal junction adenocarcinoma: a case report. Seminars in Oncology. https://www.sciencedirect.com/science/article/pii/S0093775426001168?dgcid=rss_sd_all
“No recurrent severe immune-related hepatitis during PD-L1 therapy after PD-1-related hepatitis in advanced gastroesophageal junction adenocarcinoma: a case report.” Seminars in Oncology.
@article{article65788,
title = {No recurrent severe immune-related hepatitis during PD-L1 therapy after PD-1-related hepatitis in advanced gastroesophageal junction adenocarcinoma: a case report},
journal = {Seminars in Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0093775426001168?dgcid=rss_sd_all}
}